ARMISTICE CAPITAL, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Enlivex Therapeutics Ltd. (ENLV)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Enlivex Therapeutics Ltd. Ordinary Shares, par value NIS 0.40 per share
Symbol: ENLV
Shares outstanding: 22.6M shares
Disclosed Ownership: 2.21M shares
Ownership: 9.75%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 05:43 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	9.75%	2.21M	0	2.21M	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	9.75%	2.21M	0	2.21M	/s/ Steven Boyd	Steven Boyd